Aethlon Medical Inc RSI
Was ist das RSI von Aethlon Medical Inc?
RSI von Aethlon Medical Inc ist 45.48
Was ist die Definition von RSI?
Der relative Stärke-Index (RSI 14) ist ein Momentumindikator, der die Größe von Gewinnen und Verlusten über einen bestimmten Zeitraum vergleicht, um die Geschwindigkeit und die Änderung von Preisbewegungen eines Wertpapiers zu messen.
It is used to identify overbought or oversold conditions in the trading of an asset. It oscillates between 0 and 100 and a stock is considered overbought when the RSI is above 70 and oversold when below 30. The relative strength index (RSI) is typically used on a 14-day timeframe and is calculated according to the formula 100 - [ 100 / (1 + RS)] where RS is the ratio of average gain to average loss. In the calculation of average gain and loss for a certain period, taking the prior value plus the current value is a smoothing technique similar to that used in calculating an exponential moving average. This also means that RSI values become more accurate as the calculation period extends.
Sudden large price movements can create false buy or sell signals in the RSI. The RSI is often used in conjunction with trend lines, as trend line support or resistance often coincides with support or resistance levels in the RSI reading. Watching for divergence between price and the RSI indicator is another means of refining its application. Divergence occurs when a security makes a new high or low in price but the RSI does not make a corresponding new high or low value. Bearish divergence, when price makes a new high but the RSI does not is taken as a sell signal. Bullish divergence that is interpreted as a buy signal occurs when price makes a new low, but the RSI value does not.
RSI von Unternehmen in Industrials Sektor auf NASDAQ im Vergleich zu Aethlon Medical Inc
Was macht Aethlon Medical Inc?
the aethlon medical (nasdaq:aemd) mission is to create innovative devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. our aethlon adapt™ platform provides the technology foundation for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. the aethlon adapt™ product pipeline includes the hemopurifier®, a first-in-class medical device with broad-spectrum capabilities against exosomes that contribute to the progression of cancer and infectious viral pathogens such as hiv and hepatitis c.
Unternehmen mit rsi ähnlich Aethlon Medical Inc
- Mahindra CIE Automotive hat RSI von 45.47
- Baillie Gifford Japan Trust Plc hat RSI von 45.47
- Prime Focus hat RSI von 45.47
- B. Riley Inc hat RSI von 45.47
- Tecogen Inc hat RSI von 45.47
- LKS hat RSI von 45.47
- Aethlon Medical Inc hat RSI von 45.48
- Times Neighborhood hat RSI von 45.49
- Lotto24 AG hat RSI von 45.49
- UNEEQO hat RSI von 45.49
- Sunshine Oilsands hat RSI von 45.49
- Fortune Bay hat RSI von 45.49
- Geekco Technologies hat RSI von 45.49